SeaCrest Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,497
Closed -$282K 575
2026
Q1
$282K Buy
4,497
+295
+7% +$20.5K 0.03% 489
2025
Q4
$295K Sell
4,202
-327
-7% -$21.1K 0.03% 467
2025
Q3
$307K Sell
4,529
-18
-0.4% -$1.42K 0.03% 458
2025
Q2
$397K Sell
4,547
-149
-3% -$11.7K 0.04% 379
2025
Q1
$321K Buy
4,696
+249
+6% +$20.3K 0.04% 455
2024
Q4
$346K Buy
4,447
+20
+0.5% +$1.48K 0.04% 448
2024
Q3
$297K Buy
4,427
+6
+0.1% +$493 0.03% 496
2024
Q2
$501K Buy
4,421
+152
+4% +$19.2K 0.06% 316
2024
Q1
$592K Sell
4,269
-8
-0.2% -$1.01K 0.07% 275
2023
Q4
$530K Sell
4,277
-3,002
-41% -$307K 0.07% 294
2023
Q3
$679K Buy
7,279
+106
+1% +$11.9K 0.09% 237
2023
Q2
$922K Sell
7,173
-15
-0.2% -$1.81K 0.12% 182
2023
Q1
$835K Buy
7,188
+8
+0.1% +$896 0.11% 200
2022
Q4
$813K Buy
7,180
+177
+3% +$19.4K 0.12% 204
2022
Q3
$564K Buy
7,003
+2,670
+62% +$226K 0.09% 264
2022
Q2
$323K Buy
4,333
+273
+7% +$24.9K 0.04% 444
2022
Q1
$519K Buy
4,060
+164
+4% +$17.9K 0.06% 344
2021
Q4
$523K Sell
3,896
-424
-10% -$60.9K 0.06% 345
2021
Q3
$591K Sell
4,320
-16
-0.4% -$2.02K 0.07% 292
2021
Q2
$463K Buy
4,336
+212
+5% +$20.4K 0.06% 358
2021
Q1
$371K Sell
4,124
-92
-2% -$8.64K 0.05% 400
2020
Q4
$390K Buy
4,216
+168
+4% +$15K 0.05% 353
2020
Q3
$417K Sell
4,048
-8
-0.2% -$836 0.07% 293
2020
Q2
$411K Sell
4,056
-384
-9% -$34.4K 0.07% 293
2020
Q1
$299K Sell
4,440
-1,024
-19% -$63.7K 0.06% 329
2019
Q4
$299K Sell
5,464
-188
-3% -$8.92K 0.05% 401
2019
Q3
$211K Buy
5,652
+292
+5% +$11.3K 0.04% 478
2019
Q2
$201K Hold
5,360
0.04% 462
2019
Q1
$160K Hold
5,360
0.03% 535
2018
Q4
$161K Buy
5,360
+200
+4% +$6.34K 0.03% 488
2018
Q3
$185K Buy
5,160
+100
+2% +$3.1K 0.03% 529
2018
Q2
$120K Hold
5,060
0.02% 662
2018
Q1
$94K Hold
5,060
0.02% 723
2017
Q4
$73K Buy
+5,060
New +$65.8K 0.01% 824

Other funds holding DXCM

SeaCrest Wealth Management's DXCM Position: Q2 2026 in Review

SeaCrest Wealth Management sold out of DexCom (DXCM) in Q2 2026, closing a stake of 4,497 shares — an estimated $282K sold.

SeaCrest Wealth Management first reported a position in DXCM in Q4 2017 and held it in 34 quarters. The position peaked at $922K in Q2 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • SeaCrest Wealth Management reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • SeaCrest Wealth Management sold 4,497 DexCom shares in Q2 2026, an estimated $282K.
  • SeaCrest Wealth Management first reported a position in DexCom in Q4 2017 and held it in 34 quarters.
  • SeaCrest Wealth Management's DexCom position peaked at $922K in Q2 2023.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.